臨床経験を積む一方で、循環器領域の研究を長年にわたり行い、心臓再生医療、心臓腫瘍に関する論文を数多く執筆しました。
Leukemia inhibitory factor, a potent
cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat
cardiomyocytes.
Kodama H, Fukuda K, Pan J, Makino S, Baba A,
Hori S, Ogawa S.
Circ Res. 1997 Nov;81(5):656-63.
Biphasic activation of the
JAK/STAT pathway by angiotensin II in rat cardiomyocytes.
Kodama H, Fukuda K, Pan J, Makino S, Sano M,
Takahashi T, Hori S, Ogawa S.
Circ Res. 1998 Feb
9;82(2):244-50.
Significance of ERK cascade compared with
JAK/STAT and PI3-K pathway in gp130-mediated cardiac
hypertrophy.
Kodama H, Fukuda K, Pan J, Sano M, Takahashi
T, Kato T, Makino S, Manabe T, Murata M, Ogawa S.
Am J Physiol Heart Circ Physiol.
2000 Oct;279(4):H1635-44.
Role of EGF Receptor and Pyk2 in
endothelin-1-induced ERK activation in rat cardiomyocytes.
Kodama H, Fukuda K, Takahashi T, Sano M,
Kato T, Tahara S, Hakuno D, Sato T, Manabe T, Konishi F, Ogawa
S.
J Mol Cell Cardiol. 2002
Feb;34(2):139-50.
Cardiomyogenic differentiation in cardiac
myxoma expressing lineage-specific transcription factors.
Kodama H, Hirotani T, Suzuki Y, Ogawa S,
Yamazaki K.
Am J Pathol. 2002
Aug;161(2):381-9.
Selective involvement of
p130Cas/Crk/Pyk2/c-Src in endothelin-1-induced JNK
activation.
Kodama H, Fukuda K, Takahashi E, Tahara S,
Tomita Y, Ieda M, Kimura K, Owada KM, Vuori K, Ogawa S.
Hypertension. 2003 Jun;41(6):1372-9. Epub
2003 Apr 28.
Cardiomyogenic potential of mesenchymal
progenitors derived from human circulating CD14+
monocytes.
Kodama H, Inoue T, Watanabe R, Yasuoka H,
Kawakami Y, Ogawa S, Ikeda Y, Mikoshiba K, Kuwana M.
Stem Cells Dev. 2005
Dec;14(6):676-86.
Neurogenic potential of progenitors derived
from human circulating CD14+ monocytes.
Kodama H, Inoue T, Watanabe R, Yasutomi D,
Kawakami Y, Ogawa S, Mikoshiba K, Ikeda Y, Kuwana M.
Immunol Cell Biol. 2006
Apr;84(2):209-17.
|
